Circadian-immune-related gene signature for lung squamous cell carcinoma: machine learning and multi-omics analysis

Jun 17, 2026Translational cancer research

Gene patterns linking body clock and immune system in lung squamous cell cancer using machine learning and multiple data types

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

A six-gene circadian-immune-related gene prognostic signature (CIGPS) was developed from 1,677 genes in 494 lung squamous cell carcinoma patients.

The CIGPS effectively stratified patients into high- and low-risk groups based on overall survival outcomes.
Two distinct subtypes, C1 and C2, were identified, with C1 showing higher CD8+ T cell infiltration but greater physical barriers, while C2 exhibited an immune-cold phenotype.
The subtypes displayed different therapeutic vulnerabilities and drug sensitivity profiles.
Single-cell RNA sequencing revealed a heterogeneous distribution of the signature genes across various tumor microenvironmental compartments.

AI simplified

BACKGROUND: Circadian disruption promotes tumor progression and therapy resistance, but its prognostic value and impact on the tumor immune microenvironment in lung squamous cell carcinoma (LUSC) remain unclear. This study aimed to develop a circadian-immune-related gene signature to improve LUSC risk stratification and therapy guidance.

METHODS: We integrated multi-omics data from LUSC patients (n=494) across The Cancer Genome Atlas and Gene Expression Omnibus (GEO) database GSE73403 (n=69). A circadian-immune-related gene prognostic signature (CIGPS) was constructed from 1,677 circadian rhythm-related genes through weighted gene co-expression network analysis (WGCNA) and ten machine learning algorithms (StepCox + GBM optimized) and externally validated. Bioinformatics analyses assessed the tumor immune microenvironment, mutation landscape, and therapy response. Single-cell RNA sequencing data (GSE148071) explored gene expression at cellular resolution.

RESULTS: A six-gene CIGPS was developed, comprising,,,,, and. This signature stratified patients into high- and low-risk groups with divergent overall survival in both cohorts. Unsupervised clustering revealed C1/C2 subtypes: C1 displayed an immune-hot yet excluded phenotype with higher CD8+ T cell infiltration but elevated physical barriers; C2 exhibited an immune-cold phenotype with DNA replication and epigenetic machinery activation. Both subtypes demonstrated distinct therapeutic vulnerabilities and divergent drug sensitivity profiles. Single-cell profiling demonstrated heterogeneous spatial distribution of signature genes across distinct tumor microenvironmental compartments. CLDN1FGG ALPL TREM1NKX2-1CLDN5

CONCLUSIONS: The CIGPS serves as a potent prognostic tool that elucidates the heterogeneous tumor immune microenvironment in LUSC. It holds significant promise for guiding risk assessment and informing personalized therapeutic strategies based on distinct molecular subtypes.

Full Text

Full text is available at the source.

View full text ↗

Circadian-immune-related gene signature for lung squamous cell carcinoma: machine learning and multi-omics analysis

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief